A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

The COVID-19 pandemic transformed over the past five years from a catastrophic threat that has killed over 7 million people ...

During the first address to Congress of his second term this week, President Donald Trump bragged about the accomplishments ...

In the west of Kenya, near the shores of Lake Victoria, where I come from, a tuberculosis outbreak is no different from one ...

There is no disagreement that foreign aid makes a difference; more resources are needed, not less. An estimated US$22 billion ...

Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

President Donald Trump made numerous false claims in his Tuesday speech to a joint session of Congress. The falsehoods ...

Understanding how ... A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus.